Bjerre

About Steen Bjerre

This author has not yet filled in any details.
So far Steen Bjerre has created 370 blog entries.

Efficacy and Safety of Takhzyro Injection During Extended Study Treatment Period

2019-11-11T17:17:54+01:00November 11, 2019|HAEi News|

Takeda Pharmaceutical Company Limited announces new data that further investigate the long-term safety and efficacy of TAKHZYRO® (lanadelumab-flyo) injection in patients with HAE 12 years of age and older studied in the ongoing Phase 3 HELP  (Hereditary Angioedema Long-term Prophylaxis) Study™ Open-label Extension (OLE). The analyses, being presented at the 2019 American College of Allergy, Asthma [...]

48-week results from Biocryst’s APeX-S and APeX-2 trials

2019-11-07T14:50:11+01:00November 7, 2019|HAEi News|

BioCryst Pharmaceuticals, Inc. announces the 48-week results from its APeX-S and APeX-2 trials and comprehensive market research which support the significant commercial opportunity for oral, once daily BCX7353 in HAE. “The 48-week clinical trial data we now have from APeX-S and APeX-2 highlight the control patients are having over their attacks with oral, once daily [...]

BioCryst positioned for a transformational 2020

2019-11-07T14:39:58+01:00November 7, 2019|HAEi News|

Announcing the financial results for the third quarter ended 30 September 2019 BioCryst Pharmaceuticals, Inc., President and CEO Jon Stonehouse says: “BioCryst is positioned for a transformational 2020, with the potential approval and launch of BCX7353 in the U.S. and regulatory filings for BCX7353 in Japan and Europ. We are also actively evaluating multiple approaches to add capital [...]

BioCryst partners with Torii in Japan

2019-11-05T15:06:45+01:00November 5, 2019|HAEi News|

BioCryst Pharmaceuticals, Inc. has licensed commercialization rights in Japan to Torii Pharmaceutical, Co. for BCX7353, an oral, once-daily treatment for the prevention of HAE attacks. “We are excited to partner with Torii to accelerate access for Japanese patients to BCX7353,” said Jon Stonehouse, president and CEO of BioCryst. “Torii has a strong and recent history [...]

News from Lithuania

2019-11-04T15:16:11+01:00November 4, 2019|Europe, Lithuania|

HAE Lithuania has signed up as the 81st member organization of HAE International. Laura Malinauskiene is the national contact for Lithuania.

News from Estonia

2019-11-04T15:13:40+01:00October 25, 2019|Estonia, Europe|

We are happy to inform you that HAE International has been joined by country no. 80. A warm welcome to Estonia, represented by national contact Kristal Kaljula.

News from Armenia

2019-10-21T08:14:51+01:00October 17, 2019|Armenia, Central Asia|

HAE International is happy to inform you that country no. 79 - Armenia - has just been added to our global map. The national contact in Armenia is Artashes Harutyunyan.

News from Slovenia

2019-10-12T16:16:09+01:00October 12, 2019|Slovenia|

An article about HAE has been published in a media in Slovenia in which Teja Iskra from HAE Slovenia discussed her experience with HAE and professor Mitja Kosnik from the Golnik Clinic explained about the disease genetics and treatment options.

News from North Macedonia

2019-10-12T16:15:02+01:00October 12, 2019|North Macedonia|

On 30 August 2019, an annual charity party with more than 200 attendees was organized in Skopje, North Macedonia. The party was hosted by Ms. Nora Buklevska and Mr. Petar Kajevski – two enthusiasts who strive to bring about positive changes and constructive mindset in a mundane environment. This year the funds raised were intended for HAE Macedonia. The team of [...]